Pethidine Injection BP 100mg/2ml

Страна: Ирландия

Язык: английский

Источник: HPRA (Health Products Regulatory Authority)

Купи это сейчас

Активный ингредиент:

PETHIDINE HYDROCHLORIDE

Доступна с:

Martindale Pharmaceuticals Ltd

код АТС:

N02AB; N02AB02

ИНН (Международная Имя):

PETHIDINE HYDROCHLORIDE

дозировка:

100/2 milligram(s)/millilitre

Фармацевтическая форма:

Solution for injection

Тип рецепта:

Product subject to prescription which may not be renewed (A)

Терапевтические области:

Phenylpiperidine derivatives; pethidine

Статус Авторизация:

Not marketed

Дата Авторизация:

1996-12-13

Характеристики продукта

                                SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Pethidine Injection BP 100mg/2ml
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each 2 ml ampoule contains 100 mg of pethidine hydrochloride.
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Solution for injection.
A clear, colourless to pale yellow solution, free from visible
particles.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Pethidine is a narcotic analgesic with similar actions to morphine.
Relief of moderate to severe pain.
As a premedication.
Obstetric analgesia.
Enhancement of analgesia.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Adults
_For moderate or severe pain._
Normal single dose (usually not to be repeated more often than 4
hourly).
By intramuscular or subcutaneous injection
25 - 100 mg.
By slow intravenous injection
25 - 50 mg.
_For obstetric analgesia._
By intramuscular or subcutaneous injection repeated 1 – 3 hours
later.
50 - 100 mg.
Maximum of 400mg in 24 hours.
_As a premedication._
By intramuscular or subcutaneous injection
25 – 100mg
(one hour prior to the operation)
_For the enhancement of analgesia._
By slow intravenous injection.
10 – 25mg as required.
Elderly or debilitated patients
Initial doses should not exceed 25mg as this group of patients may be
especially sensitive to the central depressant
effect of the drug.
Children
I
R
I
S
H
M
E
D
I
C
I
N
E
S
B
O
A
R
D
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_2_
_7_
_/_
_0_
_9_
_/_
_2_
_0_
_1_
_1_
_C_
_R_
_N_
_ _
_2_
_1_
_0_
_1_
_7_
_2_
_1_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
                                
                                Прочитать полный документ
                                
                            

Поиск оповещений, связанных с этим продуктом

Просмотр истории документов